Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated…
ELEVANCE HEALTH $ELV JUST REPORTED Q3 EARNINGS - Revenue: $50.44B, beating est. of $49.21B ? - Adj EPS: $6.99, beating est. of $4.68 ? - Benefit Expense Ratio: 90.6% (+70 bps YoY) - GAAP EPS: $6.27 (+17.9% YoY) - Operating Margin: 2.5% (-10 bps YoY) - Total Medical Membership:…
WATCH OUT FOR THESE STOCKS REPORTING EARNINGS TOMORROW Tomorrow before the market opens: NextEra Energy $NEE AT&T $T Abbott $ABT Moody's $MCO Phillip Morris $PM Thermo Fisher $TMO Elevance $ELV CME Group $CME Danaher $DHR Tomorrow after the stock market closes: Tesla $TSLA…
Big names reporting this week (nasdaq calendar, $40b+ market cap): PREVIEW LIVE! tue (today) pre: $GE $RTX $MMM $GM $NOC $MSCI (already out) after close: $NFLX $ISRG $COF $CB $AMX wed pre: $PM $TMO $ABT $NEE $T $DHR $CME $ELV $MCO after close: $META $TSLA $LRCX $SAP $TXN $IBM…
HERE'S WHAT THE ?? STOCK MARKET LOOKED LIKE TODAY Up: Meta $META +3.4% Accenture $ACN +2.8% Verizon $VZ +2.7% Boston Scientific $BSX +2.7% ConocoPhillips $COP +2.6% Prologis $PLD +2.3% Elevance Health $ELV +2.3% TJX $TJX +2.3% Down: Ciena $CIEN -10.0% Lumentum $LITE -9.8% Bloom…
22 analysts rate ELV Buy on consensus.
Consensus price target: $479.62 (+8.8% upside from $440.82)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| BOUDREAUX GAIL director, President and CEO | Jul 17, 2026 | Purchase | 680 | $249.16K |
| BOUDREAUX GAIL director, President and CEO | Jul 17, 2026 | Purchase | 2,045 | $753.07K |
| PERU RAMIRO G director | Jul 17, 2026 | Purchase | 1,000 | $366.05K |
| Dixon Robert L JR director | Jun 11, 2026 | Sale | 151 | $60.67K |
| Penczek Ronald W CAO & Controller | May 19, 2026 | Sale | 1,531 | $617.19K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $199.13B | +12.62% | $5.66B |
| 2024 | $176.81B | +3.19% | $5.98B |
| 2023 | $171.34B | +9.42% | $5.99B |
Stock data for ELV: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics